Skip to Main Content (Press Enter)

Logo UNINSUBRIA
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Attività
  • Competenze

UNI-FIND
Logo UNINSUBRIA

|

UNI-FIND

uninsubria.it
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Attività
  • Competenze
  1. Pubblicazioni

RETROVIROLOGY

Rivista
Codice:
E185861
ISSN:
1742-4690
  • Dati Generali

Dati Generali

Pubblicazioni (13)

  • crescente
  • decrescente
A dual defensive role of CIITA against retroviral infections
Abstract
Dynamic features of the selective pressure on the human immunodeficiency virus type 1 (HIV-1) gp120 CD4-binding site in a group of long term non progressor (LTNP) subjects.
Articolo
Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL
Articolo
Localization, quantization and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL
Abstract
MHC class II transactivator CIITA inhibits Tax-2-mediated HTLV-2 LTR transactivation and viral replication by binding to and affecting Tax-2 intracellular localization
Abstract
Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1
Articolo
The MHC Class II transactivator CIITA inhibits the persistent activation of NF-kB by Tax-1
Abstract
The MHC class II transactivator (CIITA): a "physiologic" drug against HIV-1 replication
Abstract
The MHC class II transactivator (CIITA): a physiologic inhibitor of HTLV-2 retroviral infection.
Abstract
The MHC class II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation.
Abstract
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic virus type 1.
Abstract
The immunological basis of tumor therapy by targeted delivery of TNFa to tumor vessels
Abstract
The molecular and cellular basis of tumor rejection after vaccination with mammary adenocarcinoma cells transduced with the MHC class II transactivator CIITA
Abstract
No Results Found
  • «
  • ‹
  • {pageNumber}
  • ›
  • »
{startItem} - {endItem} di {itemsNumber}
  • Accessibilità
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.9.2.0